These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9085325)

  • 1. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.
    Grant DM; Mauskopf JA; Bell L; Austin R
    Pharmacotherapy; 1997; 17(2):333-41. PubMed ID: 9085325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-consequence models for varicella-zoster virus infections.
    Paul JE; Mauskopf JA; Bell L
    Pharmacotherapy; 1995; 15(5 Pt 2):49S-58S. PubMed ID: 8577631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
    J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Efficacy Against Herpes Zoster and Costs Difference Between Acyclovir and Valaciclovir in Hematological Patients.
    Usami E; Kimura M; Iwai M; Teramachi H; Yoshimura T
    In Vivo; 2016 09-10; 30(5):701-5. PubMed ID: 27566094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster.
    Kurokawa I; Murakawa K; Kumano K
    Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
    Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of newer antiviral agents for herpes zoster: is the evidence spotty?
    Smith KJ; Roberts MS
    J Infect Dis; 1998 Nov; 178 Suppl 1():S85-90. PubMed ID: 9852982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation.
    Tilden DP; Chapman J; Davey PJ; Solly ML; Crowley S
    Clin Transplant; 2004 Jun; 18(3):312-20. PubMed ID: 15142054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
    Legendre C; Beard SM; Crochard A; Lebranchu Y; Pouteil-Noble C; Richter A; Durand-Zaleski I
    Eur J Health Econ; 2005 Jun; 6(2):172-82. PubMed ID: 15765243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
    Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T
    Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
    Tyring SK; Beutner KR; Tucker BA; Anderson WC; Crooks RJ
    Arch Fam Med; 2000; 9(9):863-9. PubMed ID: 11031393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valaciclovir: a review of its use in the management of herpes zoster.
    Ormrod D; Goa K
    Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).
    Decroix J; Partsch H; Gonzalez R; Mobacken H; Goh CL; Walsh L; Shukla S; Naisbett B
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):23-33. PubMed ID: 10877249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of serum prostate-specific antigen levels following varicella-zoster infection and valaciclovir treatment in prostate cancer.
    Jurhill RR; van der Veen H; van Leenders GJ; Verhagen PC
    Eur Urol; 2009 Aug; 56(2):392-4. PubMed ID: 19278776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
    Mauskopf JA; Richter A; Annemans L; Maclaine G
    Pharmacoeconomics; 2000 Sep; 18(3):239-51. PubMed ID: 11147391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
    Pinder M; Wright A
    Int J STD AIDS; 2015 Nov; 26(13):971-3. PubMed ID: 25505043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.